teriflunomide accord
accord healthcare s.l.u. - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi, sérhæfður ónæmisbælandi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
coversyl novum filmuhúðuð tafla 5 mg
les laboratoires servier* - perindoprilum arginín - filmuhúðuð tafla - 5 mg
klyx endaþarmslausn
ferring lægemidler a/s (f) - docusatum natricum inn; sorbitolum - endaþarmslausn
eliquis (lyfjaver) filmuhúðuð tafla 5 mg
lyfjaver ehf. - apixabanum inn - filmuhúðuð tafla - 5 mg
elocon smyrsli 0,1 %
n.v. organon* - mometasonum fúróat - smyrsli - 0,1 %
optovite b12 stungulyf, lausn 1000 míkróg
laboratorios normon s.a. - cyanocobalaminum inn - stungulyf, lausn - 1000 míkróg
rompun vet. stungulyf, lausn 20 mg/ml
elanco animal health gmbh - xylazinum hýdróklóríð - stungulyf, lausn - 20 mg/ml
dermovat krem 0,5 mg/g
glaxosmithkline pharma a/s - clobetasolum própíónat - krem - 0,5 mg/g
kenacort-t stungulyf, dreifa 40 mg/ml
bristol-myers squibb ab* - triamcinolonum acetóníð - stungulyf, dreifa - 40 mg/ml
teriflunomide sandoz filmuhúðuð tafla 14 mg
sandoz a/s - teriflunomidum inn - filmuhúðuð tafla - 14 mg